Published in Gene Therapy Weekly, December 9th, 1996
IL-12 may be useful against infectious diseases and as an anticancer therapeutic. Several studies have demonstrated that systemic administration of IL-12 could effectively induce tumor regression in several animal models.
C. Asselin-Paturel and colleagues recently presented results of a study examining the antitumor effects of direct gene transfer of IL-12 into tumors at the First Joint Meeting of the International Cytokine Society and the International Society for Interferon and Cytokine Research, held October 6-10, 1996, in Geneva,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.